We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

PTAB Denies Novartis' Challenge To Cancer Drug Patents

Law360 (January 18, 2019, 7:36 PM EST) -- The Patent Trial and Appeal Board has declined to review two Plexxikon Inc. patents related to a skin cancer treatment, dealing a setback to Novartis Pharmaceuticals Corp., which is facing infringement...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.